Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shepherd

Showing results (931-940 of 1,281) with videos related to

Pageof 129
Sort By:
Experimental Physiology|May 23, 2022
Muscle oxygenation during normoxic and hypoxic cycling exercise in humans with high-affinity haemoglobinKevin L Webb, Ahmed N Elshaer, Paolo B Dominelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10Pascal Sève, Raymond Lai, Keyue Ding, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 11, 2016
Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non-Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsAlona Zer, Keyue Ding, Siow Ming Lee, et al.
Clinical Lung Cancer|March 2, 2016
Cetuximab Inhibits T790M-Mediated Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in a Lung Adenocarcinoma Patient-Derived Xenograft Mouse ModelPetra Martin, Erin Stewart, Nhu-An Pham, et al.
The Journal of Nutrition|June 13, 2019
Fecal Microbial Diversity and Structure Are Associated with Diet Quality in the Multiethnic Cohort Adiposity Phenotype StudyGertraud Maskarinec, Meredith A J Hullar, Kristine R Monroe, et al.
JTO Clinical and Research Reports|February 3, 2022
Effects of Ethnicity on Outcomes of Patients With <i>EGFR</i> Mutation-Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical ResectionMike R Sung, Pascale Tomasini, Lisa W Le, et al.
Gastroenterology|December 24, 2008
Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasiaSimon J Leedham, Trevor A Graham, Dahmane Oukrif, et al.
Experimental Hematology & Oncology|November 22, 2014
Activity of dalotuzumab, a selective anti-IGF1R antibody, in combination with erlotinib in unselected patients with Non-small-cell lung cancer: a phase I/II randomized trialTeresa Moran, Enriqueta Felip, Vicki Keedy, et al.
The Journal of Physiology|January 11, 2020
Influence of high affinity haemoglobin on the response to normoxic and hypoxic exercisePaolo B Dominelli, Chad C Wiggins, Sarah E Baker, et al.
Biotechnology Annual Review|October 12, 2005
A prospective, non-randomised phase 1-2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphomaCarol Anne Sawka, Frances A Shepherd, Edmee Franssen, et al.
Pageof 129

Showing results (931-940 of 1,281) with videos related to

Sort By:
Pageof 129
Experimental Physiology|May 23, 2022
Muscle oxygenation during normoxic and hypoxic cycling exercise in humans with high-affinity haemoglobinKevin L Webb, Ahmed N Elshaer, Paolo B Dominelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10Pascal Sève, Raymond Lai, Keyue Ding, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 11, 2016
Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non-Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsAlona Zer, Keyue Ding, Siow Ming Lee, et al.
Clinical Lung Cancer|March 2, 2016
Cetuximab Inhibits T790M-Mediated Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in a Lung Adenocarcinoma Patient-Derived Xenograft Mouse ModelPetra Martin, Erin Stewart, Nhu-An Pham, et al.
The Journal of Nutrition|June 13, 2019
Fecal Microbial Diversity and Structure Are Associated with Diet Quality in the Multiethnic Cohort Adiposity Phenotype StudyGertraud Maskarinec, Meredith A J Hullar, Kristine R Monroe, et al.
JTO Clinical and Research Reports|February 3, 2022
Effects of Ethnicity on Outcomes of Patients With <i>EGFR</i> Mutation-Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical ResectionMike R Sung, Pascale Tomasini, Lisa W Le, et al.
Gastroenterology|December 24, 2008
Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasiaSimon J Leedham, Trevor A Graham, Dahmane Oukrif, et al.
Experimental Hematology & Oncology|November 22, 2014
Activity of dalotuzumab, a selective anti-IGF1R antibody, in combination with erlotinib in unselected patients with Non-small-cell lung cancer: a phase I/II randomized trialTeresa Moran, Enriqueta Felip, Vicki Keedy, et al.
The Journal of Physiology|January 11, 2020
Influence of high affinity haemoglobin on the response to normoxic and hypoxic exercisePaolo B Dominelli, Chad C Wiggins, Sarah E Baker, et al.
Biotechnology Annual Review|October 12, 2005
A prospective, non-randomised phase 1-2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphomaCarol Anne Sawka, Frances A Shepherd, Edmee Franssen, et al.
Pageof 129